Zdrowie i gospodarka · 25/02/2013
FDA Releases Draft Guidance on Hepatitis C Virus Resistance Data Submission
The FDA has released a draft guidance to help industry sponsors submit hepatitis C virus resistance data, crucial for the review of investigational antiviral products for HCV treatment.